NCT03857971

Brief Summary

The objective of this study is to compare the clinical outcome of Non-ST-elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI) patients with non-obstructive, non-culprit coronary lesions and either presence or absence of vulnerable plaque characteristics as assessed by optical coherence tomography (OCT).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
438

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 14, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 28, 2019

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2025

Completed
Last Updated

September 17, 2021

Status Verified

September 1, 2021

Enrollment Period

3.8 years

First QC Date

February 27, 2019

Last Update Submit

September 16, 2021

Conditions

Keywords

Vulnerable plaqueOptical coherence TomographyOCT

Outcome Measures

Primary Outcomes (1)

  • Major Adverse Cardiac Events

    Composite of all cause mortality, non-fatal myocardial infarction or unplanned revascularization.

    2 years

Secondary Outcomes (3)

  • Major Adverse Cardiac Events

    1 year

  • Major Adverse Cardiac Events

    5 years

  • Target lesion Failure

    2 and 5 years

Study Arms (1)

Coronary OCT imaging of non flow-limiting lesion

OTHER

Coronary OCT imaging will be performed of fractional flow reserve (FFR) negative lesions to assess plaque morphology.

Device: Coronary Optical Coherence tomography

Interventions

Optical coherence tomography imaging is performed of non-obstructive, non-culprit coronary lesions to assess plaque morphology.

Coronary OCT imaging of non flow-limiting lesion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed consent must be obtained.
  • Patients with STEMI or NSTEMI and residual, non-culprit CAD, with the possibility of plaque vulnerability.
  • Residual plaque(s) is(are) non-obstructive (FFR≥0.80).

You may not qualify if:

  • Refusal or inability to provide informed consent.
  • \< 18 years of age
  • Hemodynamic instability, respiratory failure, Kilip class ≥ 3.
  • Previous Coronary Artery Bypass Grafting (CABG).
  • Indication for revascularization by CABG.
  • Anatomy or lesions unsuitable for OCT catheter crossing or imaging (aorta-ostial lesions, small diameter segment, severe calcifications, lesion is too distal for OCT catheter)
  • Pregnancy.
  • Estimated life expectancy \< 3 year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboudumc

Nijmegen, South Holland, 6500HB, Netherlands

Location

Related Publications (3)

  • Volleberg RHJA, Rroku A, Mol JQ, Hermanides RS, van Leeuwen M, Berta B, Meuwissen M, Alfonso F, Wojakowski W, Belkacemi A, Roleder T, Kedhi E, van Royen N; COMBINE (OCT-FFR) and PECTUS-obs investigators. FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs. Circ Cardiovasc Interv. 2025 Feb;18(2):e014667. doi: 10.1161/CIRCINTERVENTIONS.124.014667. Epub 2025 Jan 22.

  • Volleberg RHJA, Mol JQ, Belkacemi A, Hermanides RS, Meuwissen M, Protopopov AV, Laanmets P, Krestyaninov OV, Lacle CF, Oemrawsingh RM, van Kuijk JP, Arkenbout K, van der Heijden DJ, Rasoul S, Lipsic E, Rodwell L, Camaro C, Damman P, Roleder T, Kedhi E, van Leeuwen MAH, van Geuns RM, van Royen N. High-risk plaques in non-culprit lesions and clinical outcome after NSTEMI vs. STEMI. Eur Heart J Cardiovasc Imaging. 2025 Jan 31;26(2):197-206. doi: 10.1093/ehjci/jeae289.

  • Mol JQ, Belkacemi A, Volleberg RH, Meuwissen M, Protopopov AV, Laanmets P, Krestyaninov OV, Dennert R, Oemrawsingh RM, van Kuijk JP, Arkenbout K, van der Heijden DJ, Rasoul S, Lipsic E, Teerenstra S, Camaro C, Damman P, van Leeuwen MA, van Geuns RJ, van Royen N. Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study. BMJ Open. 2021 Jul 7;11(7):e048994. doi: 10.1136/bmjopen-2021-048994.

MeSH Terms

Conditions

Myocardial InfarctionAcute Coronary SyndromeCoronary Artery Disease

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisCoronary DiseaseArteriosclerosisArterial Occlusive Diseases

Study Officials

  • Niels van Royen, MD, PhD

    Radboud University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2019

First Posted

February 28, 2019

Study Start

December 14, 2018

Primary Completion

September 15, 2022

Study Completion

June 14, 2025

Last Updated

September 17, 2021

Record last verified: 2021-09

Locations